Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the Swiss Association against Osteoporosis (SVGO/ASCO). (2017). Swiss Medical Weekly, 147(3334), w14484. https://doi.org/10.4414/smw.2017.14484